Navigation Links
How and why did 2011 Nobel winner Dan Shechtman persist despite rejection?
Date:10/14/2011

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

On October 5, 2011, Shechtman received the Nobel Prize in Chemistry.

What compelled Shechtman to stand by his research? What drove the men and women behind the most paradigm-shifting findings of the twentieth century? What motivates those few scientists who rise above their peers to achieve breakthrough discoveries?

In order to answer such questions, physical chemist and author Istvan Hargittai examines the careers of fifteen eminent scientists who achieved some of the most notable discoveries of the past century, assessing their motivation. In Drive and Curiosity, Dr. Hargittai provides an insider's perspective on the history of twentieth-century science. The author, who was personally acquainted with all but two of the scientists he profiles, includes:

  • Dan Shechtman, the aforementioned 2011 Nobel laureate and discoverer of quasicrystals
  • James D. Watson, the Nobel laureate and codiscoverer of the double helix structure of DNA
  • Linus Pauling, the Nobel laureate remembered most for his work on the structure of proteins
  • Edward Teller, a giant of the twentieth century who accomplished breakthroughs in our understanding of nuclear fusion
  • George Gamow, a pioneering scientist who devised the initially ridiculed and now accepted Big Bang

"Is there a recipe for research successes reaching the highest pinnacles? What are the common characteristics of discoveries that profoundly alter the world we live in?" asks Richard N. Zare, Stanford University, Wolf Prize laureate. "This fascinating book presents fifteen case studies that explore these questions in a manner both inviting and at once accessible."

In each case, Hargittai has uncovered a singular personality characteristic, motivational factor, or circumstance that, in addition to their extraordinary drive and curiosity, led these scientists to make outstanding contributions. For example, Gertrude B. Elion, who discovered drugs that saved millions of lives, was motivated to find new medications after the deaths of her grandfather and later her fianc. F. Sherwood Rowland, who stumbled upon the environmental harm caused by chlorofluorocarbons, eventually felt a moral imperative to become an environmental activist. Rosalyn Yalow, the codiscoverer of the radioimmunoassay, always felt she had to prove herself in the face of prejudice against her as a woman.

When it comes to "science, discovery and scientists," adds Nobel laureate Jean-Marie Lehn, it matters to be "the right person, at the right time, in the right place. This book provides a thoughtful and vivid analysis of how scientific progress happens through some selected case studies. It should be of value to [anyone] who wishes to get insight into the various processes underlying the quest for knowledge."


'/>"/>
Contact: Meghan Quinn
mquinn@prometheusbooks.com
800-853-7545
Prometheus Books
Source:Eurekalert  

Related medicine news :

1. Nobel Prize in Physiology or Medicine 2011: Jules Hoffmann
2. UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine
3. Lifespan researcher wins Ig Nobel Prize
4. Nobel laureates Brown, Goldstein to give inaugural Stadtman award lecture
5. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
6. NIDA Avant-Garde-Medications Development Award winners announced
7. HJF names 2011-12 fellowship award winners
8. Joint winners announced in Research4life global case study competition
9. BUS Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner
10. Reed Elsevier Environmental Challenge winners announced
11. Cephalalgia Award Lecture winner announced
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How and why did 2011 Nobel winner Dan Shechtman persist despite rejection?
(Date:5/24/2016)... ... 2016 , ... Global Lyme Alliance (GLA), a leading nonprofit ... has named Scott Santarella as its new CEO. , Santarella is former ... San Francisco, where he successfully helped to grow the organization from a regional ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers ... of protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The ... Interventions (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts ... ‘El Centro del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was ... offer something special for this often overlooked neighborhood. Located at 609 E. 6th ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in ... kicked off its 5th Annual Photo Contest. The label contest is underway, and ... year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... On the ... took the time to summarize the weight loss process: , New patients have a ... Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are 15 ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... , May 23, 2016 The ... USD 5.0 billion by 2022, according to a new ... of medical waste coupled with the lack of centralized ... expected to drive the demand for reprocessed medical devices ... as compared to that of the original device is ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: